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Abstract: Polymorphisms that occur in the CYPlAt, CYP|T and TNF-o genes affects hlperkeratinzation process, se-
bum production and inflammation in acne wlgaris. Polymorphisms ofCYPlAl, CYPl7 and TNF-a genes can be idsntified
by using PCR and sequencing techniques. The aim of this study is to dcmonstrate the role of polymorphisms of CYP I A I ,
CYP17, and TNF-a genes and th€ interaction polimorphisms ofCYPlAl, CYPI? and TNF-a genes to s€vere acne wlgaris.
This study was conducted as an observational study with case-control method, in 64 patients with severe acne, and as con-
trols 73 patients with mild acne and healthy people. Criteria bas€d on Combined Acne Severity Classification. Biospesimen
blood I ml taken from vena mediana cubiti then performed PCR and sequencing to determire the sequence of nucleotides
in DNA fiagments. The conclution from the study shows that polymorphisms ofCYPlAl, CYPI?, TNF-c genes and the
interaction polimorphisms ofCYPlAl, CYP 17 and TNF-c genes is oot a risk factor for severe acne vulgaris, but pol).rnor-
phism ofCYPl Al gene is a risk factor for acne vulgaris.
Keywords: Severe Acne Vulgaris, Polymorphisms ofCYPIAl, CYPI7, and TNF-a gcnes, Interactions polymorphisms
ofCYPlAl, CYP | 7 and TNF-c genes
l. Introduction
Acne vulgaris (AV) is a common skin disease, as well as
on our society in Indonesia (r). Acne does not tbreatcn life
but it often become a cosmetic problem in the form of se-
vere AV resulting scar formation, and often leads to psy-
chological complains, and even lead to lack of confidence
in a person {' '). In a study conducted by Abdel-Hafez et al
(2009) demonstrated psychiatric synptoms suah as anxiety,
depression, paranoia, and psychosis related to AV and
showed legative effect on tho quality oflife ofpatieuts o).
Acne vulgaris is a chronic inflammatory pilos€baceous
follicle disease, characterized by comedones, papuJes, pus-
tules, nodules, and sometimes scars. Acne primarily aff€cts
the face, neck, upper &unk and upper arms {"). Acne rulga-
ris is mainly found in adolescence and adulthood, and often
at a younger age or older(r). ln the United States this dis-
ease affects 4G50 million people each year(5), and the
number of visits to the dermatologist are at 20plo of a visits(o). From the medical record at several hospitals in Indone-
sia in 2008, obtained a high number of AV patienrs visits in
some hospitals in Indonesia, among others, Dr Wahidin
Sudirohusodo Hospital there were 22 visits (21% of all AV
patient visit), in Dr Moh. Hoesin Palembang Hospital there
were 20 visits (6% ofall AV patients visit), and Dr. Sardjito
Yogyakarta Hospital there were 97 visis (9% of all AV
patient visit)
Acne cao be caused by severul factots, zuch as sxcess
sebum production, follicular hyperkeratinization, prolifera-
tion of Propionibacterium acnes (P- acnes), inflammation.
and genetics (7).
Several genes that may influence the occurlence of AV
including gene CYP lAl, CYP l7 and TNF-{. Research
conducted in Germany showed that CYP lAl gene poly-
morphisms causing the lack of an active natural retinoids
resulting in follicular hiperkeratinization resulting AV (4-
CYPIT gene that encodes cytochrome P450cl7a is an en-
4.me in androgen biosynthesis that mediares thc activity of
steroid l?a-hydroxylase and 17,20-lyase. Th€ presence of
CYP l? gene polynorphism affects the activity of the 
€n-
zyme CYP 17 that will change the levels of androgen,
progcsterone and esfrogcn hormones. Androgens increase
sebum production and follicular keratosis which plays an
important role in the develqpment of acne (8). Tumor necro-
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sis factor-alpha (TNF-0) is one of the proinflammatory
c)4okines that initiate and r€gulate the flow of cytokines
during the inflammatory response, The factors that caus€
changes in the production of TNF-0 may influence the de-
gree of inflammation. The existence of polymorphism in
the TNF-(r g€ne can increase the production of TNF-a and
aggravate AV (e). Expression of TLR2 and TNF-c by kera-
tinocytes induced by P. acnes in acne inllammatory phase
(10)
The results ofCYP tAl, CYP 17 and TNF-o gene poly-
morphisms in AV is still very limited, and the results of
research that has been done in Makassar who get results are
not statistically significant between ffP l7 gene polymor-
phisms and progression of severe acne, prompted us to per-
form research on gene polymorphisms CYP lA1, CYP
genes 17 and TNF-C genes and theit interactions in AV
2. Material and Methods
This study is an observational study with case-control
method, in which the cases were severe acne patients arrd
the controls were patients with mild acne and healthy
people. The study was conducted in the Departrnent of
Dermatology and Venereology Hasanuddin University, Wa-
hidin Sudirohusodo Hospital and network hospitals, labom-
tory of Microbiology, Faculty of Medicine Hasanuddin
University in Makassar, and laboratory Eijkman in Jakarta
in March 2010-September 201l.
The study population was divided into two charact€rs,
namely tle case with the following inclusion criteria: pa-
tients with severe acne based on Combined Acne Severity
Classification criteria, those are assessed by a d€rmatolo-
gist and patients signed the informed consent. While the
excluded case criteria were: patients with severe acne who
received antibiotics and anti-inflammatory medication for I
month, patients with severe acne who use hormonal contra-
ceptives, patient with severe acne who smoke, patients with
sever€ acne who are pregnant and breastfeeding. Inclusion
criteria for the control group were patients with mild acne
and healthy people on the same age witl the case and
agreed to and signed informed consent. As for the exclu-
sion criteria for the contlol group were mild acne pattents
who received antibiotics and anti-inflammatory medication
for I month, patients with mild acne who use hormonal
conhaaeptives, patients with mild acne who are smokes,
and patients with nild acne who are pregnant and breas!
feeding. Determiuation of the sample based on the table of
Rochat et al, with OR : 3.5, the value of o : 0.05, p : 0.1,
and f:0.30 is 56. ln this study, severe acne cases collected
amount 64 people and control 73 people.
Blood specimens were taken I InL of 64 patients with
severe acne as cases and 73 patients with mild acne and
healthy controls. The specimen will then b€ treated DNA
isolation (sediment) for PCR testing. PCR method is pre-
pared using DNA extract as a positive control and sterile
distilled water as a negative control.
3. Results
The number of samples in this study were 137 people
consisting of 53 males (38.77.) and 84 females (61.3%).
The sample consisted of 64 patients with severe AV, 31
males (48.4%) and 33 females (51.6%) and 73 patients urith
mild AV and healthy individuals,22 males (31.1%) and 5l
females (69.9%).
Table I shows that from 64 people with severe AY there
were 3l (51%) who had a GG genot'?e, compared to 30
(50%) with mild AV and healthy individuals. GA genoqpe
in severe AV are at 307o compared to 70% in mild AV and
healthy individuals. While the AA genotype in severe AV
58.3% compared to 41.7% in light AV and healthy individ-
uals (statistical test p = 0.032).
Tabb 1. Distiblttion ofcvPi Al genotype on the severe AV group and
nild Ay and healthy individuals gmup.
GeiotYP. CYP lAl
crouDr '- Totrl (%)
' GG('/.1 GA 1'/.t AA(u.,
Sev€re Av
Mild AV and
h€allhy indMdual
Total
3 r (50,8) r 2 (r0,0) 2t (s83) U (6,7)
30 (492) 28 (?0,0) 15 (41,7) 73 (53,3)
6r (t00,0) ,{0 ( lm,0) 36{100,0) ll7(100.t,
Note. Peanon Chi-Sqnre P = 0,032
Tabel 2 shows that from 64 people with severe AV, there
were 20 (46,50/o) who had CC genotype, compared to 23
(53,5%) with mild AV and heatthy individual. TC genotPe
exist it 44.'lvo severe acne compared to 55,3% in mild AV
and healthy individual. While the TT genotype 48.9% in
severe AV cornpared to 5 I . I % of mild AV and healthy indi-
viduals (statistical test p = 0.918).
lob., 2. Dishbdion ofCYPl T geno4pe on rhe severe.1v gtoup and nild
AY and heahhy indh,Auals gmuP
CYP 17 gcnotw.
Groups Totrl (7.)
cc (v.) rc('/., T r c/.,
Mild AV and
healthy iudividual
20 (4,s\ 2r (44,7' 23 (48,9\ 64 (4,7)
23 (53,5) 26(553) 24 (st,t) 73 (53,3)
T^,-r arrtoool 47r100.01 47{100.01 117fl00,0)
Note: Peo6on Chi-Squarc P = 0 gIu
Tabel 3 shows that from 64 people with severe AY there
were 3 (37,50/.) who had AA genol)?e' compared to 5
(62,5%) with mild Av and healthy individual. GA genorype
exist in 55,67o severe acne compared to 44,4% in mild AV
and healthy individual. White the GG genotype 46-7% in
severe AV compared to 53.3% of mild Av and healthy indi-
viduals (statistical test p : 0.757)
The resllts of analysis of the inleraction between geno-
type, whether it is in the CYP lAl, CYP 17, and TNF-0
gene in severe AV, showed that the difference was not sta-
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tistically signifi cant.
Tabte 3. Distibution of TNF-a genotype on the severe Al/ grcup and mild
AV and healthy individuab grp.
Groups
TI{F-a gcnot}Te
Total (%)
AA('/.) GA(%) ffi('/c)
Severe AV 3 (37,5) 5 (ss,6) s6 (46,',t) s (46,7)
Ivtitd.AY nTd. . . 5 (62.5) 4 (44$ 64 (53,3) 73 (s3,3)healthv individual
rotal s (100,0) e (100,0) !2q1!qQp)---!!zl
Kel: Pearson Chi-Sryare p = 0,757
4. Discussion
In this study found that the group with the genotype GG,
GA and AA give a substantial proportion of the occurrence
of cases of acne vulgaris (Table l), but the proportion of
cases with genot)?e AA higher than genotypes GG and GA.
GG and GA genotype at position that gives the proportion
of controls more than the AA genotype, this is a question to
the results in Table l.
Combined genotlpes GG and GA show properties AV
protection against the occurrence of severe cases with ER
of 0.85 (95%Cl:0.69 to l.M). The fact shows the nature of
which is not in line with expectations (GG and GA geno-
types as risk factors). The answer may lie in the selection of
mild AV were included in the control group, it may be the
genotypes GG and GA as the initial trigger pain (mild AV)
should be grouped together with severe AV. Further analy-
sis of the patients with grouping mild and severe AV as
cases and healthy individuals as controls. The results ofthe
analysis between GG and AA genotlpe of CYPIA1 gene
showed that individuals who have the GG genotype of
CYPIAI genes have ER 1.04 times (95% CI:0.69 to 1.55)
than individuals who have genotype AA CYPIA1 gene.
The results of the analysis between GA and AA genotype of
CYPlA1 gene showed that individuals who had GA geno'
type of CYPIAI gene have ER 0.71 times (95% Cl:0.47 to
1.07) than individuals who have genotlpe AA CYPIAI
gene. The Further analysis showed true GG genotlpe as a
risk factor and genofyping GA can not be proven as a risk
factor for acne vulgaris.
Theoretically, groups with genotypes GG and GA CYP
lAlgene has a natural retinoid levels were lower than in
the group with AA genotype. This occurance due to the
increased activity of the enzyme in the metabolism and
inactivation of ATRA to 4-oxo-retinoic acid, so that active
natural retinoids will be reduced. Deficiency of active natu-
ral retinoids on the skin can cause abnormal differentiation
and hiperkeratinization sebosit follicular canal (7). It is well
known that vitamin A deficiency resulted in a variety of
epithelial metaplasia is accomprnied by an increase in cell
proliferation and hyperkeratosis of the skin. From several
studies in animals and infants with vitamin A deficiency,
suggesting that vitamin A deficiency causes a disease re-
sembling follicular keratosis Darier and pityriasis rubra
pilaris (ll). Hiperkeratinization follicular epithelium is one
important factor in the pathogenesis ofacne (12).
Study conducted by Paraskevaidis et al in Germany
about the role of CYP lAl gene polymorphisms in acne
showed normal frequency of m2 mutations from adenine to
guanine substitution (A to G) result a change of isoleucine
to valine amino acid which increases the activity of the
erlrryrorre. Another study focused on the development of can-
cer bronchogenic also found the effect ofthe polymorphism
of CYP 1Al gene by increasing the activity of the enzyme
(7).
Cyochrome P450cl7 is an enzyme in the synthesis of
sexual steroids. This enzpe catalyzes the lla-
hydroxylation of prepenolone and progesterone. Enzyme
activity is required in the synthesis ofandrogens and estro-
gens. CYPIT gene is a gene that codes for this enzyme (13).
Varian of polymorphic P450cl7 gene (CYPl7) encode this
enzyrne can lead to changes in the activity of CYPl7 (14).
The role of androgens in the pathogenesis of acne has
been known. (8). There is evidence that androgenic stimu-
lation of sebaceous glands important role play in the occur-
rence of acne (15). However, the actual genetic reasons,
how androgen effect on acne is still not clear (8).
CYP17 gene in this research is done as study by He et al,
in which tlte results obtained homozygous frequency C
allele CYPIT gene in a group of severe AV in men was
significantly higher than the control group. this study can
be concluded that the homozigositosis CYPI T-34C / C may
increase the risk of severe acne in men (8).
In this study, mutations of CYPIT gene occur with nuc-
leotide substitution T / C at the 5 'untranslated region (UTR)
CYPIT promoter. Alleged that the substitution T / C will
increase the rate of transcription of this enzyme in the CC
genotpe due to increased activity of promoters (1a) and
the consequence is an excessive production of glucocorti-
coids (13). Fiegelson and Haiman et al get estrogen levels
were higher in women with the A2 allele (allele C) CYPIT
gene (16, l7).
In this study was found the group with CC and TC geno-
bpe are not a risk factor for severe AV if compared with
the TT genoqpe, although the CC genoq?e had higher
androgen levels. Research by Cibula et al did not show a
positive relationship between androgen production and
severity of acne in women over the age of l7 years (18).
Another study examined the association between CYPIT
gene polymorphism in women using PCR have also been
carried out by Tian et al used 3 genotyping androgen-
related gene CYP 17 and the results showed significant
results between the genotypes of androgen is 42, A2 of the
CYPIT gene in 34 bp where there is a single base polymor-
phism on changes from T to C in the untranslated region
(-I-fR) of the CYPIT gene. The effect of increased risk of
acne in women with higher levels of androgens (19).
This study found no statistical relationship polymor-
phism with severe AV because acne is a disease that is in-
fluenced by a variety of factors, rnainly by environmental
Science Journal ofClinical Medicine 2013,2(2): 58-63
factors-
In this study the use ofTNF-a gcne promoter at position
-308 and the obtained results from 64 people with severe
AV there are 3 people (3?.5%) who had AA genotype,
compared with 5 (62.57o) with severe AV and healthy indi-
viduals. GA genotype present in 55.60lo severe AV com-
pared to 44.4V" by mild AV and healthy individuals. While
the GG genotype in severe AV compared with mild AV 46.7%
and 53.3% ofhealthy individuals (statistical test p = 0.757).
From these results it car be seen GG genotype frequency
distlibutions predominantly found in the severe AV and
mild groups and healthy individuals, and there rvas no sig-
nificant difference in genot)?e distribution in both groups
so that it can be int€rpreted that there is no relationship
between genot,?e distribution of TNF-C with severe AV.
This is consistent with research conducted Baz K et al
(2008) in ll3 patients with acne,30 of them with severe
AV and GG genotype distsibution obtained in 16 (53.3%),
genotlpe GA in 12 (40.0yo) and genoope AA in 2 (6.7%)
compared with 32 patients with mild AV GG genotype dis-
tribution of 16 (50.0%), genotype GA 15 (46.8%) and the
AA genotype I (3-2olo) with the results ofstatistical tests (p
:0.463) (9). Based on statistical tests, our study found no
siguifrcant association betwecn TNF-0 gene polymor-
phisms with severe AV events (p = 0.757). This suggests
that TNF-c getre polymorphism is not a risk factor for se-
vere AV- In accordance with the results of the study in Tur-
key found the severity of acne lulgaris genotype was not
associated with TNF-o. This can be caused by the €xpres-
sion of TNF-a genotype is associat€d with individual HLA
(20) and is also influenced by the ethnic as found in the
study by Baz K et al in several different ethnic, found also
that the frcquency of hetetozygotes genotif G / A is very
low on spare Asia (8-18%) when compared with research
on European interest (27% -35.5%) (9).
In this study, all the results of sequencing compared to
full sequencing TNFu. gene ptomoter along the 605 bas€-
pair (bp) referral of the g€ne bank using the BLAST pro-
gram (alert-2) from the webside: NBCI, and in our study
with a sample of 64 patieats with severe AV, we found 3
(4.7%) mutations at position -308. Thus the disoovery of
the G allele frequency in TNF-c gene promoter -308 domi-
nant position when compared with the fiequency ofallele A.
From the frequeocy distribution of genoqD€s' mutant AA
genotyp€ was found by 3 (4.7%) which is in line with re-
search conducted in Turkcy Baz K et al who found 4 (3.5%)
of I 13 patients with acne mutations and research conducted
by Szabo K et al in Romania that found 4 (1.8o/o) of 229
patients wirh acne mutatioo (9, 21). Some research on the
analysis of atlele frequencies of TNF<! was reported by
Szabo et al in position l03l T> C,-857C> T,-863C> A'-
308G> A and-238g> A suspected role in the dcvelopment
of the inflammatory reaction in acno vulgaris . Results ob-
tained no significant differ€nces in allele frequencies be-
tween cases and controls at the position -1031, -861, -238
SNPS, whereas at position -857 and -308 obtained signifF
cant results (r = 0.010) between allele C major and acne, as
well as the minor allele at position -308 increased in pa-
tients with aan€. G nucleotide replacem€nt in the TNF-a
gene at position -308 are associated with increased han-
scriptional activity of TNF-a and increased levels of cirau-
lating TNF-a (22). Substitution of guanine (G) to adenine
(A) is also associated with increased susceptibility suffer-
ing from chronic inflammatory diseases, including acne
wlgaris (9). Some diseases are associated with polymor-
phism in the TNF-c gene at position -308 one of them is
breast cancer (23), chronic hepatitis B (22) dan schizophre-
nia (24) have been published.
Various other related studies idcntified a single nucleo-
tide polymorphism in the TNF<! gene promoter humans
have been reported, and found an association betw€€n in-
creased susceptibility to various diseases. Research in Chile
by Cuenca J et al against TNF-0 g€notlping conclude that
there is a difference in the spread of allele TNF-o and eth-
nic populatiors that have a high proportion ofallele TNF-o
is also likely to have iocreas€d the incidence of multiple
metabolic diseases predisposing to chronic, degenerative
diseases, inflammatory and autoimmune diseases. This
indicates that there is a diversity of resuls of each minor
alletes of several different tribes and populations and
changes in one or two copies of chromosome 6 in the plo-
moter regior of thc TNF gene cluster contained in the HLA
class Itr genes may lead to increased risk ofvarious diseas-
es (25)- From the results of our study and compared with
some previous studies that have been published can be con-
cluded that TNF-q gene polymorphism at position -308 in
touch with a person suffering from acne vulgaris vulnera-
biliry but not related to the d€gree of severity of acne vul-
garis.
Therefore, further discussion is necessary to see the ef-
fects of retinoid therapy in severe AV group. Retinoid ther-
apy is given in the form of topical tr€tinoin 0.05 to 0 l%
and / or oral isotretinoin. The proportion of patients with
severe AV who got irrprovement after retinoid thqraPy,
with GG genotype of CYPIAI gene 50%, while those with
the AA genotypc of CYPIAI gene as much as 42.9Vo. This
suggests that administration of retinoids in severe AV pa-
tients with CYPIAI gene polymorphisms proYide a betler
outcome tian severe AV patients without CYPIAI gene
polymorphisms, which are consistent with the theory that
the group with the GG and GA genotypcs of CYP lAl
gene has a lower natural retinoid levels than in group with
the AA genotype, thus, giving retiuoid provide irnprove-
ments in severe AV patients with CYPIAI gene polymor-
phism,
This study still remains questions thet has not been com-
pleted answered. From the thtee gene polymorphisms stu-
died, only further analysis of CYPIAI gene polymor-
phisms showing the GG g€notype of CYPIAI gene as a
risk factor for acne lulgaris. Theoretically, individuals vrith
the GG genotlpe ofCYPlAl gene can be fall into active
nahral retinoid deficiency (7). Therefore, further discus-
sion is necessary to see the effects of retinoid therapy in
severe AV group. Retinoid therapy is given in the form of
6t
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topical tretinoin 0.05 to 0.lo/o and / or oral isotretinoin. The
proportion of patients with severe AV who got improve-
ment after retinoid therapy, with GG genotlpe of CYPIAI
gene 5O%o, while those with the AA genotype of CYPIAI
gene as much as 42.9%. This suggests that administration
of retinoids in severe AV patients with CYPIAI gene po-
lymorphisms provide a better outcome than severe AV pa-
tients without CYPIAI gene polymorphisms, which are
consistent with the theory that the group with the GG and
GA genotypes of CYP lAl gene has a lower natural retino-
id levels than in group with the AA genotype, thus, giving
retinoid provide improvements in severe AV patients with
CYPI Al gene polymorphism.
The proportion of patients who experienced severe AV
have repair after receive retinoid therapy with CC genotype
CYP17 gene by 607o, while those with the TT geno6/pe
CYP17 gene as much as 42.9oh. That administration of
retinoids in patients with severe AV CYPIT gene polymor-
phism provides better results. Notice, in the group of the
CYP17 gene with the CC genot)?e have higher androgen
levels (18). There is evidence to convince that androgenic
stimulation of sebaceous have role play in acne (15). In
vitro, isotretinoin and ATRA is a potent inhibitor of cell
proliferation and lipid synthesis in human sebosit and reti-
noids that decrease the synthesis of triglycerides and free
fatty acids in the culture sebosit (26), so that adminishation
of retinoid is expected to provide improvements in patients
with severe AV the CYPI T gene polymorphism.
The proportion of patients who experienced severe AV
repair after receiving retinoid therapy with AA genotype of
TNF-a gene as much as 33.3%, while those with GG geno-
type of TNF-o gene as much as 47 .lVo. That administration
of retinoids in patients with severe AV with TNF-o gene
polymorphism did not give better results than patients
without severe AV TNF-a gene polymorphism. Theoretical-
ly, the G nucleotide substitution in the gene TNF-o -308
locations with nucleotide A in individuals with the TNF-a
gene polymorphisms resulting in elevated levels of TNF-tr
can influence the degree of inflammation and severity of
acne (9). The role of retinoids in the treatment of AV is
through keratolytic activity and regulation of proliferation
and differentiation to eliminate comedones (27) and inhibit
the secretion ofthe sebaceous glands (28) thereby granting
retinoids can not be expected to provide more improvement
in patients with severe AV gene polymorphisms of TNF-c
than patients without severe AV TNF-a gene polymorphism.
Overall the test results showed no significant probability
value, however is still visible from the statistical test data
showing the positive direction toward the severe AV.
5. Conclusion
CYPIAI gene polymorphism is not a risk factor for se-
vere AV but it is a risk factor for acne vulgaris. CYPIT
gene and TNF-a polymorphism are not risks factor for se-
vere AV. The interaction between gene polymorphisms of
CYPlAl, CYPIT gene and TNF-o gene is also not a risk
factor for severe AV. It is need to perform a measurement of
natural retinoids, the 4-oxo retinoic acid, the rate of sebum,
the hormones androgen and TNF-o level in relation to the
influence of CYPIAI gene polymorphisms, gene CYPIT
and TNF-a gene expression in the creation of severe AV.
Should be examined other genes that may play a role in the
creation ofheavyAV-
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